生物医药品的製造能力及生产量(2023年):趋势与分析用贵重的资源，第20届年度报告

该报告研究了生物製药的製造能力和产量，提供了市场概况，包括生物加工挑战、生物製药製造的外包、一次性和一次性系统以及供应商趋势。

目录

第0章

• 人口动态

第1章

• 简介和讨论

第2章

• 生物製程的重要问题概要

第3章

• 生物医药品的製造的新问题

第4章

• 容量使用率

第5章

• 现在及未来的容量规定

第6章

• 未来的容量扩张

第7章

• 生物医药品的製造的外包趋势

第8章

• 生物医药品的製造的抛弃式及单回使用系统

第9章

• 下游的精製

第10章

• 生物医药品的製造的僱用，僱用的扩大，进修

第11章

• 新的方法，持续性及流程强化，细胞及基因治疗

第12章

• 生物医药品製造及生命科学的供应商

An Invaluable Resource for Trends & Analysis

473+ pages of data-rich analysis to help improve your decision making in biomanufacturing. In-depth analysis of capacity, production trends, benchmarks, and more!

The 2023 20^th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production is a comprehensive analysis of trends and opportunities, biotherapeutic developers and contract manufacturing organizations' current and projected future capacity and production. We also provide case study summaries highlighting a specific issue affecting the industry, an overview of the situation, and a discussion summary.

"The BioPlan Annual Report and Survey is and has always been a must read, as it is the most comprehensive survey and result analysis to determine trends, requirements and new demand of the biopharmaceutical industry." - Maik Jornitz, President, G-Con, LLC.

• 207 Biopharma companies
• 138 industry vendors and direct suppliers
• 25 Countries represented
• 473 Pages
• 12 Chapters
• 200+ Graphs and 20+ Tables
• Subject Matter Expert analysis
• Independent Sponsoring Organizations

COVERAGE:

• In-depth analysis of key data, capacity, production trends, and benchmarks

• Budget trends and impact of the current economic environment

• Downstream purification problems and issues

• Current and projected industry bottlenecks

• Capacity utilization and current production levels

• Capacity bottlenecks - what's being done to resolve

• Production trends and Outsourcing trends

• International offshoring through 2028

• Range of titers, growth

• Disposables: Spending growth; downstream uses; L&E's; reasons for increasing/ restricting; budget increases; vendor satisfaction

• Batch failure rates & trends

• Selecting a CMO - Problems & solutions

• Quality management & PAT implementation

• Hiring and employment growth

• Supplier growth rates, and much more

TABLE OF CONTENTS

CHAPTER 0:

• Demographics

CHAPTER 1:

• Introduction and Discussion

CHAPTER 2:

• Overview of Critical Issues in Bioprocessing

CHAPTER 3:

• Emerging Issues in Biopharmaceutical Manufacturing

CHAPTER 4:

• Capacity Utilization

CHAPTER 5:

• Current and Future Capacity Constraints

CHAPTER 6:

• Future Capacity Expansions

CHAPTER 7:

• Outsourcing Trends in Biopharmaceutical Manufacturing

CHAPTER 8:

• Disposables and Single-Use Systems in Biopharmaceutical Manufacturing

CHAPTER 9:

• Downstream Purification

CHAPTER 10:

• Hiring, Employment Growth and Training in Biopharmaceutical Manufacturing

CHAPTER 11:

• New Methods, Continuous and Process Intensification, Cell and Gene Therapy

CHAPTER 12:

• Suppliers to Biopharmaceutical Manufacturing and Life Sciences